These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23103699)

  • 1. Pump exchange for cable damage in patients supported with HeartMate II left ventricular assist device.
    Potapov EV; Kaufmann F; Stepanenko A; Hening E; Vierecke J; Löw A; Lehmkuhl E; Dranishnikov N; Hetzer R; Krabatsch T
    ASAIO J; 2012; 58(6):578-82. PubMed ID: 23103699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions.
    Soltani S; Kaufmann F; Vierecke J; Kretzschmar A; Hennig E; Stein J; Hetzer R; Krabatsch T; Potapov EV
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):984-9. PubMed ID: 25209626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous lead dysfunction in the HeartMate II left ventricular assist device.
    Kalavrouziotis D; Tong MZ; Starling RC; Massiello A; Soltesz E; Smedira NG; Fryc R; Heatley G; Farrar DJ; Moazami N
    Ann Thorac Surg; 2014 Apr; 97(4):1373-8. PubMed ID: 24492061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience.
    Loforte A; Montalto A; Ranocchi F; Casali G; Luzi G; Monica PL; Sbaraglia F; Polizzi V; Distefano G; Musumeci F
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):765-71. PubMed ID: 19465866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
    J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of HeartMate II Short-to-Shield Patients With an Ungrounded Cable: Indications and Long-Term Outcomes.
    Coyle L; Graney N; Gallagher C; Paliga R; Yost G; Pappas P; Macaluso G; Tatooles A
    ASAIO J; 2020 Apr; 66(4):381-387. PubMed ID: 31045924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.
    Haft JW; Suzuki Y; Aaronson KD; Dyke DB; Wright S; Poirier VL; Pagani FD
    ASAIO J; 2007; 53(3):298-303. PubMed ID: 17515718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoratec implantable ventricular assist device: the Papworth experience.
    Berman M; Parameshwar J; Jenkins DP; Dhital K; Lewis C; Dempster K; Lincoln P; Sudarshan C; Large SR; Dunning J; Tsui SS
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):466-73. PubMed ID: 19833355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique.
    Potapov EV; Stepanenko A; Kaufmann F; Henning E; Vierecke J; Lehmkuhl E; Hetzer R; Krabatsch T
    ASAIO J; 2013; 59(1):37-40. PubMed ID: 23263342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.